Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2008
12/03/2008CN100439397C Crystallization of IGF-1
12/03/2008CN100439394C Pharmaceutical use for secreted bacterial effector proteins
12/03/2008CN100439393C Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food
12/03/2008CN100439370C Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/03/2008CN100439360C Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
12/03/2008CN100439344C 4-anilino quinazoline derivatives as antiproliferative agents
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100438919C Nucleic acid vaccine, and its application
12/03/2008CN100438912C Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof
12/03/2008CN100438911C Body weight gain inhibitor
12/03/2008CN100438906C The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy
12/03/2008CN100438905C Stable liquid formulations of botulinum toxin
12/03/2008CN100438888C Freeze-dried preparation containing honeysuckle flower and astragalus root and its preparing method
12/03/2008CN100438885C Active ginseng crisp and its preparation
12/03/2008CN100438881C Application of crocodile blood in process for preparing anticancer antivirus and immunity improving medicine and health caring food
12/03/2008CN100438870C Method for treating diseases with omega interferon
12/03/2008CN100438862C Composition for administration to mucosa and containing coenzyme Q as active ingredient
12/02/2008USRE40594 Inhibitors of the bitter taste response
12/02/2008US7459601 Animal model for use in monitoring aggregation of alpha -synuclein non-amyloid component (NAC) and identifying agent for treatment of nervous system disorders; neuroprotective agents
12/02/2008US7459552 Reacting N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide with 5-benzyloxy-2-mercaptobenzimidazole in presence of triphenylphosphine and diethyl azodicarboxylate; acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459538 Recombinant tumor specific antibody and use thereof
12/02/2008US7459524 Polypeptide of given sequence; use in vaccines
12/02/2008US7459481 Adust fatty acid oxidation; stimulant of carnitine plamitoyl treansferrase
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents
12/02/2008US7459465 Isoquinoline compound and pharmaceutical use thereof
12/02/2008US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459455 Pyrimidine compounds
12/02/2008US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008US7459440 Ocular tear growth factor-like protein
12/02/2008US7459432 adminsteration of Peptide YY or an agonist to a overweight subject, or having obesity related disorders, results in decreased food intake, caloric intake, appetite, and an alteration in energy metabolism
12/02/2008US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety.
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459291 Chordin-like molecules and uses thereof
12/02/2008US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens
12/02/2008CA2516108C Polymorphs of donepezil hydrochloride and process for production
12/02/2008CA2469315C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/02/2008CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
12/02/2008CA2397404C Micronized freeze-dried particles
12/02/2008CA2394230C Novel stromelysin inhibitors
12/02/2008CA2377668C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2341624C Stable spray-dried protein formulations
12/02/2008CA2313878C Composition for suppressing behavior problems of pets
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
12/02/2008CA2303395C Treatment of obesity
12/02/2008CA2278715C Aminooxy-modified oligonucleotides
12/02/2008CA2257803C Non immunosuppressive antifungal rapalogs
12/02/2008CA2205085C An in vitro system for determining formation of a.beta. amyloid
12/02/2008CA2186380C Novel carbamates and ureas as modifiers of multi-drug resistance
12/02/2008CA2153604C Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields
11/2008
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008143637A2 Compositions and methods for making therapies delivered by viral vectors reversible for safety or allele-specificity
11/27/2008WO2008143545A1 Agent for stimulating lymphatic drainage
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008143262A1 Heterocyclic compound and use thereof
11/27/2008WO2008143254A1 Pharmaceutical containing pparδ agonist
11/27/2008WO2008142986A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11 β-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY
11/27/2008WO2008142862A1 Anticancer therapy by transplanting vascular endothelial progenitor cells
11/27/2008WO2008142860A1 Novel sweetener having sugar-like taste and production method and use of the same
11/27/2008WO2008142859A1 Novel spiro-oxindole compound and pharmaceutical containing the same
11/27/2008WO2008141897A1 Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
11/27/2008WO2008141570A1 A composition for improving quality of fetus, preventing and treating birth defects
11/27/2008WO2008141357A1 Dendritic molecules
11/27/2008WO2008051505A3 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
11/27/2008WO2007130365A3 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
11/27/2008US20080293962 Novel compounds of the N-acylamino amide family compositions comprising them and uses thereof
11/27/2008US20080293791 Valsartan salts
11/27/2008US20080293732 Substituted pyrazoles
11/27/2008US20080293698 Methods and Compositions for Treating Arg
11/27/2008US20080293673 N-acetyglucosamine derivatives and use thereof
11/27/2008US20080293667 Lipid analogs for combating tumors
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293656 Processing nucleic acid
11/27/2008US20080293654 Therapeutic methods using Smads
11/27/2008US20080293643 Crystalline Form I of 3,4'5-Trihydroxy-Stilbene-3-B-D Glucoside
11/27/2008US20080293632 Use of natriuretic peptides for the treatment of stature disorders related to shox gene
11/27/2008US20080293625 Diagnosis of Inflammatory Bowel Diseases, More Particularly Ulcerative Colitis
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080292735 Regulating alkaloids
11/27/2008US20080292712 Methods and compositions for enhanced delivery of bioactive molecules
11/27/2008US20080292710 Liquid Dosage Forms Of Acid Labile Drugs
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292701 Lansoprazole dosage forms; fast disintegration in the oral cavity even without water
11/27/2008US20080292699 Solid pharmaceutical dosage unit for alleviating symptoms of rhinorrhea
11/27/2008US20080292694 Opioid agonist/antagonist combinations
11/27/2008US20080292666 Preparation for Preventing or Treating Calcium Deficiency Conditions In Mammals
11/27/2008US20080292643 Leukocyte inactivation module
11/27/2008US20080292636 Chemokine panec-2 polynuleotides, polypeptides, antibodies and methods of making and using them
11/27/2008US20080292627 Compositions and Methods for Treating Mood and Anxiety Disorders
11/27/2008US20080292623 Mammalian cell membrane proteins; related reagents
11/27/2008US20080292610 Medicaments containing enzymes from ciliates for promoting digestion in digestive disorders
11/27/2008US20080292598 Chimeric transplant
11/27/2008US20080292594 reduced expression of a sigma3 polypeptide; used to generate and stably propagate infectious subviral particle (ISVP); proliferative disorder
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 1564